Cadila Pharmaceuticals Ltd. is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of affordable medicines for patients worldwide. With a history spanning over seven decades, the company has established itself as one of the few vertically-integrated pharmaceutical firms, boasting a strong presence in both Active Pharmaceutical Ingredients (API) and Finished Formulations. Cadila’s extensive portfolio includes over 850 products across various formulations, catering to 45 therapeutic segments and 12 specialties such as Cardiovascular, Gastrointestinal, analgesics, haematinics, anti-infectives, respiratory agents, antidiabetics, immunologicals, and oncology.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Finished Dosage Forms
– Contract Manufacturing (CMO/CDMO)
– Contract Research Organisation (CRO)
– Generics/Biosimilars
– Pharmaceutical Development

Cadila Pharmaceuticals Ltd. is committed to providing high-quality healthcare solutions that meet the diverse needs of patients globally. For more detailed information, please visit cadilapharma.com.